Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
CLD/NIN@LIEV decreases the nonspecific phagocytosis of nanoparticles and suppresses the inflammatory cytokines secreted by Kupffer cells, thus enhancing the therapeutic effects against liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Murray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds
Farooqi, A. A., Desai, N. N., Qureshi, M. Z., Librelotto, D. R. N., Gasparri, M. L., Bishayee, A., Nabavi, S. M., Curti, V., & Daglia, M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.010 · Cited by 359
Research works printed but not linked: 24
- Seniutkin, 2018, Toxicol. Appl. Pharmacol., 339, 1, 10.1016/j.taap.2017.11.024 · DOI
- Berumen, 2021, Wiley Interdiscip. Rev.: Syst. Biol. Med., 13, e1499, 10.1002/wics.1499 · DOI
- Koyama, 2019, Am. J. Respir. Cell Mol. Biol., 60, 478, 10.1165/rcmb.2018-0098OC · DOI
- Mohammadalipour, 2019, Clin. Exp. Pharmacol. Physiol., 46, 1183, 10.1111/1440-1681.13157 · DOI
- Varone, 2018, Expert Opin. Pharmacother., 19, 167, 10.1080/14656566.2018.1425681 · DOI
- Wollin, 2020, BioMed Res. Int., 2020, 3867198, 10.1155/2020/3867198 · DOI
- Feng, 2021, Kidney Dis., 7, 34, 10.1159/000509670 · DOI
- Cai, 2018, J. Cell. Mol. Med., 22, 5050, 10.1111/jcmm.13787 · DOI · Paper page
- Roth, 2015, J. Med. Chem., 58, 1053, 10.1021/jm501562a · DOI · Paper page
- Aghebati-Maleki, 2020, J. Cell Physiol., 235, 1962, 10.1002/jcp.29126 · DOI · Paper page
- Peng, 2021, Biomed. Pharmacother., 137, 111342, 10.1016/j.biopha.2021.111342 · DOI · Paper page
- Luo, 2019, ACS Nano, 13, 3910, 10.1021/acsnano.8b06924 · DOI · Paper page
- Qiao, 2020, J. Controlled Release, 321, 629, 10.1016/j.jconrel.2020.02.049 · DOI · Paper page
- Lin, 2016, J. Controlled Release, 221, 62, 10.1016/j.jconrel.2015.11.003 · DOI
- Giannitrapani, 2014, World J. Gastroenterol., 20, 7242, 10.3748/wjg.v20.i23.7242 · DOI · Paper page
- Kuznik, 2020, Eur. J. Pharmacol., 866, 172773, 10.1016/j.ejphar.2019.172773 · DOI
- van Rooijen, 2010, Methods Mol. Biol., 605, 189, 10.1007/978-1-60327-360-2_13 · DOI · Paper page
- Sun, 2021, Biomaterials, 271, 120761, 10.1016/j.biomaterials.2021.120761 · DOI · Paper page
- Poelstra, 2011, J. Hepatol., 55, 726, 10.1016/j.jhep.2011.04.008 · DOI · Paper page
- Iwakiri, 2014, J. Hepatol., 61, 912, 10.1016/j.jhep.2014.05.047 · DOI · Paper page
- Tsochatzis, 2008, Aliment. Pharmacol. Ther., 27, 80, 10.1111/j.1365-2036.2007.03538.x · DOI
- Kooijmans, 2017, Nat. Biomed. Eng., 1, 634, 10.1038/s41551-017-0119-4 · DOI
- Fallatah, 2016, Hepatitis Mon., 16, e38346
- Shrestha, 2016, Food Chem. Toxicol., 93, 129, 10.1016/j.fct.2016.04.024 · DOI
Cited by
Research progress in membrane fusion-based hybrid exosomes for drug delivery systems
Liu, A., Yang, G., Liu, Y., & Liu, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.939441 · Cited by 88
Liu, J., Liu, J., Mu, W., Ma, Q., Zhai, X., Jin, B., Liu, Y., & Zhang, N. (2024) · ACS Nano · doi:10.1021/acsnano.4c02380 · Cited by 74
Extracellular vesicles: emerging therapeutic agents for liver fibrosis
Chiabotto, G., Semnani, A., Ceccotti, E., & Bruno, S. (2025) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.08 · Cited by 13
Li, Z., Zhang, Q., Xiang, J., Zhao, M., Meng, Y., Hu, X., Li, T., Nie, Y., Sun, H., Yan, T., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100653 · Cited by 8
Metadata
- Authors
- Ji, K., Fan, M., Huang, D., Sun, L., Li, B., Xu, R., Zhang, J., Shao, X., & Chen, Y.
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 10
- Issue
- 3
- Pages
- 702-713
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W4200247641
- Cited by
- 41
- References
- 12
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-04-11)
- Open access
- closed
- Funders
- Natural Science Foundation of Shanghai (19ZR1472500)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.